Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Altimmune Inc. logo

Altimmune Inc.

Sector: Healthcare   

Industry: Biotechnology

8.40
 
USD
  
-0.36
  
(-4.11%)
Optionable: Yes  Market Cap: 455 M  90-day average vol: 12,281,699

Previous close: 8.76  Open: 8.53  Bid: 8.38  Ask: 8.4
52 week range    
2.09   
   13.00
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Wednesday 21st February 2024
40
MarketXLS Rank
40
Value
30
Technical
52
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ALT Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends368548.05 M3 M452925.0
Basic EPS total-2.4-1.2-0.689.1-1.91-2.35-1.81
Basic weighted shares outstanding2 M2 M2 M2 M426836.03 M13 M26 M41 M47 M
Cost of sales-40000.0-100000.0-100000.0
Depreciation182487.0149958.0141604.0-63109.0-83834.0-218717.0-239821.0-300000.0-400000.0-500000.0
Depreciation unreconciled182487.0149958.0141604.0143437.0
DepreciationAndAmortization182487.0149958.0141604.0-63109.0-83834.0-218717.0-239821.0-300000.0-400000.0-500000.0
Diluted EPS total-6.9-5.1-1.588.5-120.3-15.16-1.6-1.91-2.35-1.81
Diluted weighted shares outstanding2 M2 M2 M2 M385913.03 M13 M26 M41 M47 M
GainOnSaleOfSecurity-444622.0508817.0299477.0-957070.090384.0-3 M30000.0
GeneralAndAdministrativeExpense13 M11 M6 M7 M8 M10 M9 M13 M15 M17 M
Gross operating profit18 M10 M11 M3 M11 M10 M6 M8 M4 M-68000.0
ImpairmentOfCapitalAssets36 M25 M1000000.0
Income before tax-12 M-10 M-3 M-11 M-52 M-45 M-21 M-54 M-97 M-85 M
Income restructuring and M&A-3 M3 M-249643.0
Income taxes61746.061746.061746.011 M-6 M-6 M-58500.0-5 M-197000.0
Interest income2575.0-229192.01047.047579.0226597.0873409.0322514.0202741.03 M
InterestExpenseNonOperating366706.0210399.054581.038499.0162139.0297090.02244.09421.05656.08000.0
MiscOtherSpecialCharges-6071.0-762.08137.042303.05670.0277886.015139.024147.0-373868.0-32000.0
Net income from total operations-12 M-10 M-3 M-11 M-46 M-39 M-21 M-49 M-97 M-85 M
NetIncomeCommonStockholders-12 M-10 M-3 M-11 M-51 M-42 M-21 M-49 M-97 M-85 M
NetIncomeContinuousOperations-12 M-10 M-3 M-11 M-46 M-39 M-21 M-49 M-97 M-85 M
NetNonOperatingInterestIncomeExpense-366706.0-210399.0-229192.0-37452.0-114560.0-70493.0871165.0313093.0197085.03 M
NetOperatingInterestIncomeExpense-54581.0168150.0
NonRecurringOperationExpense-217 M
Operating income-11 M-10 M-856641.0-11 M-16 M-18 M-20 M-55 M-86 M-88 M
Operating income before depreciation (EBITDA)-11 M-10 M-3 M-11 M-52 M-45 M-20 M-54 M-97 M-85 M
OperatingExpense-29 M-20 M-14 M-14 M-63 M-53 M-27 M-63 M-101 M-88 M
Other income net450693.0-508055.0-307614.0-42303.0-96054.02 M-15139.0-24147.012 M32000.0
OtherGandA13 M11 M6 M7 M8 M10 M9 M13 M15 M17 M
OtherImpairmentOfCapitalAssets-36981.0-24 M-1000000.011 M
OtherOperatingExpenses-710783.0
OtherunderPreferredStockDividend368548.05 M3 M452925.0
PreferredStockDividends368548.05 M3 M452925.0
RentAndLandingFees13 M11 M6 M7 M8 M10 M9 M13 M15 M17 M
Research & development expense15 M9 M5 M7 M18 M18 M18 M50 M75 M71 M
ResearchExpense15 M9 M5 M7 M18 M18 M18 M50 M75 M71 M
RestructringAndMnAIncome-3 M3 M-249643.0
SalariesAndWages-1 M-2 M-613017.0-965365.0-1 M-773248.0-1 M-3 M-6 M-8 M
Selling Gen & administrative expense13 M11 M6 M7 M8 M10 M9 M13 M15 M17 M
Special income/charges3 M-3 M217 M-36 M-25 M-1000000.0
Total Income available for interest expense (EBIT)-11 M-10 M-3 M-11 M-52 M-45 M-21 M-54 M-97 M-85 M
Total common shares outstanding178422.0212109.0217504.0229383.0742369.013 M15 M37 M43 M49 M
Total net income-12 M-10 M-3 M-11 M-46 M-39 M-21 M-49 M-97 M-85 M
Total ordinary shares54 M54 M54 M54 M54 M54 M54 M54 M54 M54 M
Total revenues18 M10 M11 M3 M11 M10 M6 M8 M4 M-68000.0
TotalExpenses-29 M-20 M-14 M-14 M-63 M-53 M-27 M-63 M-101 M-88 M
TotalRevenue18 M10 M11 M3 M11 M10 M6 M8 M4 M-68000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University